From: Differences in iNOS inhibition in an animal model of acute hepatic and multi-organ failure
 |  |  |  |  |  |  |  |  | Mortality |
---|---|---|---|---|---|---|---|---|---|
 | AST (iu/l) | PT (s) | Ammonia (μg/ml) | Lactate (mmol/l) | (%) |  | |||
Hours | 24 | 72 | 24 | 72 | 24 | 72 | 24 | 72 | 96 |
G1, TAA | 1653 ± 338 | 3166 ± 612 | 18 ± 3 | 121 ± 12 | 54 ± 12 | 169 ± 34 | 2.6 ± 0.8 | 5.26 ± 1 | 75 |
G2, Pre-AMG | 346 ± 102 | 1486 ± 341* | 32 ± 3* | 43 ± 7* | 47 ± 10* | 75 ± 14* | 1.9 ± 0.2* | 3.5 ± 0.4* | 10* |
G3, Pre-L-Name | 1780 ± 441 | 5179 ± 606* | >121* | >121 | 90 ± 10 | 151 ± 11 | 4.3 ± 0.3 | 6.5 ± 0.3 | 80 |
G4, Post-AMG | 2188 ± 450 | 5069 ± 512* | >121* | >121 | 132 ± 12 | 167 ± 8 | 3.3 ± 0.3 | 7.8 ± 0.6 | 100 |
G5, Post-L-Name | 1897 ± 327 | 5468 ± 268* | >121* | >121 | 139 ± 5 | 168 ± 9 | 4.2 ± 0.5 | 7.9 ± 0.5 | 100 |